Development of a Simple Genotyping Method for the Hla-A*31:01-Tagging Snp in Japanese

References

• Roujeau JC . Clinical heterogeneity of drug hypersensitivity . Toxicology209 ( 2 ), 123 – 129 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Kaniwa N , SaitoY . Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury . J. Hum. Genet.58 ( 6 ), 317 – 326 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• McCormack M , AlfirevicA , BourgeoisSet al. HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans . N. Engl. J. Med.364 ( 12 ), 1134 – 1143 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Ozeki T , MushirodaT , YowangAet al. Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population . Hum. Mol. Genet.20 ( 5 ), 1034 – 1041 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Chen P , LinJJ , LuCSet al. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan . N. Engl. J. Med.364 ( 12 ), 1126 – 1133 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Amstutz U , ShearNH , RiederMJet al. Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions . Epilepsia55 ( 4 ), 496 – 506 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Middleton D . History of DNA typing for the human MHC . Rev. Immunogenet.1 ( 2 ), 135 – 156 ( 1999 ).
   PubMedGoogle Scholar
• Aoki M , HosonoN , TakataSet al. New pharmacogenetic test for detecting an HLA-A*31:01 allele using the InvaderPlus assay . Pharmacogenet. Genomics22 ( 6 ), 441 – 446 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Uchiyama K , KubotaF , AriyoshiNet al. Development of a simple method for detection of the HLA-A*31:01 allele . Drug Metab. Pharmacokinet.28 ( 5 ), 435 – 438 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Niihara H , KohnoK , TaketaniTet al. Simple and rapid detection of HLA-A*31:01 for prediction of carbamazepine-induced hypersensitivity using loop-mediated isothermal amplification method . J. Dermatol. Sci.74 ( 1 ), 88 – 92 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Cheung YK , KwokM , ChanEet al. Rapid detection of HLA-A*31:01 allele in DNA and blood samples using loop-mediated isothermal amplification . Br. J. Dermatol.171 ( 1 ), 90 – 96 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• de Bakker PI , McVeanG , SabetiPCet al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC . Nat. Genet.38 ( 10 ), 1166 – 1172 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Mallal S , PhillipsE , CarosiGet al. HLA-B*5701 screening for hypersensitivity to abacavir . N. Engl. J. Med.358 ( 6 ), 568 – 579 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Colombo S , RauchA , RotgerMet al. The HCP5 single-nucleotide polymorphism: a simple screening tool for prediction of hypersensitivity reaction to abacavir . J. Infect. Dis.198 ( 6 ), 864 – 867 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Rodriguez-Novoa S , CuencaL , MorelloJet al. Use of the HCP5 single nucleotide polymorphism to predict hypersensitivity reactions to abacavir: correlation with HLA-B*5701 . J. Antimicrob. Chemother.65 ( 8 ), 1567 – 1569 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Sanchez-Giron F , Villegas-TorresB , Jaramillo-VillafuerteKet al. Association of the genetic marker for abacavir hypersensitivity HLA-B*5701 with HCP5 rs2395029 in Mexican Mestizos . Pharmacogenomics12 ( 6 ), 809 – 814 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Galvan CA , ElbarchaOC , FernandezEJet al. Rapid HCP5 single-nucleotide polymorphism genotyping: a simple allele-specific PCR method for prediction of hypersensitivity reaction to Abacavir . Clin. Chim. Acta412 ( 15–16 ), 1382 – 1384 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Maekawa K , NishikawaJ , KaniwaNet al. Development of a rapid and inexpensive assay for detecting a surrogate genetic polymorphism of HLA-B*58:01: a partially predictive but useful biomarker for allopurinol-related Stevens–Johnson syndrome/toxic epidermal necrolysis in Japanese . Drug Metab. Pharmacokinet.27 ( 4 ), 447 – 450 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kitajima H , SonodaM , YamamotoK . HLA and SNP haplotype mapping in the Japanese population . Genes Immun.13 ( 7 ), 543 – 548 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Bastuji-Garin S , RzanyB , SternRSet al. Clinical classification of cases of toxic epidermal necrolysis, Stevens–Johnson syndrome, and erythema multiforme . Arch. Dermatol.129 ( 1 ), 92 – 96 ( 1993 ).
   PubMedGoogle Scholar
• Hashimoto K , IijimaM , ShioharaTet al. Toxic epidermal necrolysis . In : Handling Manual for Individual Severe Adverse Reactions (Volume 1) . Japan Pharmaceutical Information Center , Tokyo, Japan , 21 – 35 ( 2007 ).
   Google Scholar
• Mockenhaupt M , ViboudC , DunantAet al. Stevens–Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study . J. Invest. Dermatol.128 ( 1 ), 35 – 44 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Kaniwa N , SaitoY , AiharaMet al. HLA-B*1511 is a risk factor for carbamazepine-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in Japanese patients . Epilepsia51 ( 12 ), 2461 – 2465 ( 2011 ).
   Web of Science ®Google Scholar
• Kaniwa N , SugiyamaE , SaitoYet al. Specific HLA types are associated with antiepileptic drug-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in Japanese subjects . Pharmacogenomics14 ( 15 ), 1821 – 1831 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• International HapMap Project . http://hapmap.ncbi.nlm.nih.gov/index.html.en .
   Google Scholar
• Kashiwagi M , AiharaM , TakahashiYet al. Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients . J. Dermatol.35 ( 10 ), 683 – 685 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Kim SH , LeeKW , SongWJet al. Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans . Epilepsy Res.97 ( 1–2 ), 190 – 197 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Genin E , ChenDP , HungSIet al. HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis . Pharmacogenomics J.14 ( 3 ), 281 – 288 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Hsiao YH , HuiRC , WuTet al. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations . J. Dermatol. Sci.73 ( 2 ), 101 – 109 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Chung WH , ChangWC , LeeYSet al. Genetic variants associated with phenytoin-related severe cutaneous adverse reactions . JAMA312 ( 5 ), 525 – 534 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Erlich RL , JiaX , AndersonSet al. Next-generation sequencing for HLA typing of class I loci . BMC Genomics12 , 42 ( 2011 ).
   PubMed Web of Science ®Google Scholar